• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.26% Nasdaq Down0.34%

    Sucampo Pharmaceuticals, Inc. (SCMP)

    -NasdaqGM
    17.07 Up 0.73(4.47%) Jul 6, 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014
    Total Revenue 29,480   37,757   31,463   24,069  
    Cost of Revenue6,110  4,106  4,974  3,796  
    Gross Profit 23,370   33,651   26,489   20,273  
    Operating Expenses
    Research Development6,793  5,882  5,297  4,252  
    Selling General and Administrative6,923  10,721  11,918  12,210  
    Non Recurring -   -  5,631   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss 9,654   17,048   3,643   3,811  
    Income from Continuing Operations
    Total Other Income/Expenses Net(163)1,173  545  (30)
    Earnings Before Interest And Taxes9,491  18,221  4,188  3,781  
    Interest Expense276  344  384  392  
    Income Before Tax9,215  17,877  3,804  3,389  
    Income Tax Expense2,807  8,595  2,324  1,778  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops6,408  9,282  1,480  1,611  
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income 6,408   9,282   1,480   1,611  
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares 6,408   9,282   1,480   1,611  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.